Holocaust  ||| S:0 E:10 ||| JJ
survivors ||| S:10 E:19 ||| NNS
:  ||| S:19 E:21 ||| :
the  ||| S:21 E:25 ||| DT
pain  ||| S:25 E:30 ||| NN
behind  ||| S:30 E:37 ||| IN
the  ||| S:37 E:41 ||| DT
agony ||| S:41 E:46 ||| NN
.  ||| S:46 E:48 ||| .
Increased  ||| S:48 E:58 ||| JJ
prevalence  ||| S:58 E:69 ||| NN
of  ||| S:69 E:72 ||| IN
fibromyalgia  ||| S:72 E:85 ||| NN
among  ||| S:85 E:91 ||| IN
Holocaust  ||| S:91 E:101 ||| NNP
survivors  ||| S:101 E:111 ||| NNS
To  ||| S:111 E:114 ||| TO
assess  ||| S:114 E:121 ||| VB
the  ||| S:121 E:125 ||| DT
frequency  ||| S:125 E:135 ||| NN
of  ||| S:135 E:138 ||| IN
fibromyalgia  ||| S:138 E:151 ||| NN
among  ||| S:151 E:157 ||| IN
a  ||| S:157 E:159 ||| DT
population  ||| S:159 E:170 ||| NN
of  ||| S:170 E:173 ||| IN
Holocaust  ||| S:173 E:183 ||| NNP
survivors  ||| S:183 E:193 ||| NNS
in  ||| S:193 E:196 ||| IN
Israel  ||| S:196 E:203 ||| NNP
as  ||| S:203 E:206 ||| IN
well  ||| S:206 E:211 ||| RB
as  ||| S:211 E:214 ||| IN
the  ||| S:214 E:218 ||| DT
occurrence  ||| S:218 E:229 ||| NN
of  ||| S:229 E:232 ||| IN
post-traumatic  ||| S:232 E:247 ||| JJ
stress  ||| S:247 E:254 ||| NN
disorder  ||| S:254 E:263 ||| NN
( ||| S:263 E:264 ||| -LRB-
PTSD ||| S:264 E:268 ||| NNP
)  ||| S:268 E:270 ||| -RRB-
and  ||| S:270 E:274 ||| CC
concurrent  ||| S:274 E:285 ||| JJ
psychiatric  ||| S:285 E:297 ||| JJ
symptoms ||| S:297 E:305 ||| NNS
,  ||| S:305 E:307 ||| ,
including  ||| S:307 E:317 ||| VBG
depression  ||| S:317 E:328 ||| NN
and  ||| S:328 E:332 ||| CC
anxiety  ||| S:332 E:340 ||| NN
among  ||| S:340 E:346 ||| IN
survivors ||| S:346 E:355 ||| NNS
.  ||| S:355 E:357 ||| .
Eighty-three  ||| S:357 E:370 ||| CD
survivors  ||| S:370 E:380 ||| NNS
of  ||| S:380 E:383 ||| IN
the  ||| S:383 E:387 ||| DT
Nazi  ||| S:387 E:392 ||| NNP
Holocaust  ||| S:392 E:402 ||| NNP
and  ||| S:402 E:406 ||| CC
65  ||| S:406 E:409 ||| CD
age-matched  ||| S:409 E:421 ||| JJ
individuals  ||| S:421 E:433 ||| NNS
not  ||| S:433 E:437 ||| RB
exposed  ||| S:437 E:445 ||| VBN
to  ||| S:445 E:448 ||| TO
Nazi  ||| S:448 E:453 ||| JJ
occupation  ||| S:453 E:464 ||| NN
were  ||| S:464 E:469 ||| VBD
recruited ||| S:469 E:478 ||| VBN
.  ||| S:478 E:480 ||| .
Physical  ||| S:480 E:489 ||| JJ
examination  ||| S:489 E:501 ||| NN
and  ||| S:501 E:505 ||| CC
manual  ||| S:505 E:512 ||| JJ
tender  ||| S:512 E:519 ||| NN
point  ||| S:519 E:525 ||| NN
assessment  ||| S:525 E:536 ||| NN
was  ||| S:536 E:540 ||| VBD
performed  ||| S:540 E:550 ||| VBN
for  ||| S:550 E:554 ||| IN
the  ||| S:554 E:558 ||| DT
establishment  ||| S:558 E:572 ||| NN
of  ||| S:572 E:575 ||| IN
the  ||| S:575 E:579 ||| DT
diagnosis  ||| S:579 E:589 ||| NN
of  ||| S:589 E:592 ||| IN
fibromyalgia  ||| S:592 E:605 ||| NN
and  ||| S:605 E:609 ||| CC
information  ||| S:609 E:621 ||| NN
was  ||| S:621 E:625 ||| VBD
collected  ||| S:625 E:635 ||| VBN
regarding  ||| S:635 E:645 ||| VBG
quality  ||| S:645 E:653 ||| NN
of  ||| S:653 E:656 ||| IN
life  ||| S:656 E:661 ||| NN
( ||| S:661 E:662 ||| -LRB-
SF-36 ||| S:662 E:667 ||| NNP
) ||| S:667 E:668 ||| -RRB-
,  ||| S:668 E:670 ||| ,
physical  ||| S:670 E:679 ||| JJ
function  ||| S:679 E:688 ||| NN
and  ||| S:688 E:692 ||| CC
health  ||| S:692 E:699 ||| NN
( ||| S:699 E:700 ||| -LRB-
FIQ ||| S:700 E:703 ||| NNP
) ||| S:703 E:704 ||| -RRB-
,  ||| S:704 E:706 ||| ,
psychiatric  ||| S:706 E:718 ||| JJ
symptoms  ||| S:718 E:727 ||| NNS
( ||| S:727 E:728 ||| -LRB-
SCL-90 ||| S:728 E:734 ||| NNP
)  ||| S:734 E:736 ||| -RRB-
and  ||| S:736 E:740 ||| CC
PTSD  ||| S:740 E:745 ||| NNP
symptoms  ||| S:745 E:754 ||| NNS
( ||| S:754 E:755 ||| -LRB-
CAPS ||| S:755 E:759 ||| NNP
) ||| S:759 E:760 ||| -RRB-
.  ||| S:760 E:762 ||| .
Significantly  ||| S:762 E:776 ||| RB
increased  ||| S:776 E:786 ||| VBN
rates  ||| S:786 E:792 ||| NNS
of  ||| S:792 E:795 ||| IN
fibromyalgia  ||| S:795 E:808 ||| NN
were  ||| S:808 E:813 ||| VBD
identified  ||| S:813 E:824 ||| VBN
among  ||| S:824 E:830 ||| IN
Holocaust  ||| S:830 E:840 ||| NNP
survivors  ||| S:840 E:850 ||| NNS
compared  ||| S:850 E:859 ||| VBN
with  ||| S:859 E:864 ||| IN
controls  ||| S:864 E:873 ||| NNS
( ||| S:873 E:874 ||| -LRB-
23.81 ||| S:874 E:879 ||| NNP
%  ||| S:879 E:881 ||| NN
vs.  ||| S:881 E:885 ||| IN
10.94 ||| S:885 E:890 ||| NNP
,  ||| S:890 E:892 ||| ,
p  ||| S:892 E:893 ||| CD
< ||| S:893 E:894 ||| SYM
0.05 ||| S:894 E:898 ||| CD
) ||| S:898 E:899 ||| -RRB-
.  ||| S:899 E:901 ||| .
Significantly  ||| S:901 E:915 ||| RB
increased  ||| S:915 E:925 ||| VBN
rates  ||| S:925 E:931 ||| NNS
of  ||| S:931 E:934 ||| IN
posttraumatic  ||| S:934 E:948 ||| JJ
symptoms  ||| S:948 E:957 ||| NNS
and  ||| S:957 E:961 ||| CC
measures  ||| S:961 E:970 ||| NNS
of  ||| S:970 E:973 ||| IN
mental  ||| S:973 E:980 ||| JJ
distress  ||| S:980 E:989 ||| NN
were  ||| S:989 E:994 ||| VBD
also  ||| S:994 E:999 ||| RB
identified  ||| S:999 E:1010 ||| VBN
among  ||| S:1010 E:1016 ||| IN
survivors ||| S:1016 E:1025 ||| NNS
.  ||| S:1025 E:1027 ||| .
The  ||| S:1027 E:1031 ||| DT
results  ||| S:1031 E:1039 ||| NNS
indicate  ||| S:1039 E:1048 ||| VBP
a  ||| S:1048 E:1050 ||| DT
significantly  ||| S:1050 E:1064 ||| RB
increased  ||| S:1064 E:1074 ||| VBD
prevalence  ||| S:1074 E:1085 ||| VBN
of  ||| S:1085 E:1088 ||| IN
fibromyalgia  ||| S:1088 E:1101 ||| NN
among  ||| S:1101 E:1107 ||| IN
Holocaust  ||| S:1107 E:1117 ||| NNP
survivors  ||| S:1117 E:1127 ||| VBD
six  ||| S:1127 E:1131 ||| CD
decades  ||| S:1131 E:1139 ||| NNS
after  ||| S:1139 E:1145 ||| IN
the  ||| S:1145 E:1149 ||| DT
end  ||| S:1149 E:1153 ||| NN
of  ||| S:1153 E:1156 ||| IN
the  ||| S:1156 E:1160 ||| DT
Second  ||| S:1160 E:1167 ||| NNP
World  ||| S:1167 E:1173 ||| NNP
War ||| S:1173 E:1176 ||| NNP
.  ||| S:1176 E:1178 ||| .
This  ||| S:1178 E:1183 ||| DT
finding  ||| S:1183 E:1191 ||| NN
furthers  ||| S:1191 E:1200 ||| VBD
our  ||| S:1200 E:1204 ||| PRP$
knowledge  ||| S:1204 E:1214 ||| NN
regarding  ||| S:1214 E:1224 ||| VBG
the  ||| S:1224 E:1228 ||| DT
long-term  ||| S:1228 E:1238 ||| JJ
effect  ||| S:1238 E:1245 ||| NN
of  ||| S:1245 E:1248 ||| IN
stress  ||| S:1248 E:1255 ||| NN
on  ||| S:1255 E:1258 ||| IN
the  ||| S:1258 E:1262 ||| DT
development  ||| S:1262 E:1274 ||| NN
of  ||| S:1274 E:1277 ||| IN
fibromyalgia ||| S:1277 E:1289 ||| NN
.  ||| S:1289 E:1291 ||| .
